Telemonitoring Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Telemonitoring Systems Market Report is Segmented by Product Type (COPD Telemonitoring System, Glucose Level Telemonitoring System, and More), Component (Devices, Software Platforms and More), Connectivity Technology (Bluetooth / Low-Energy and More), Application (Cardiovascular Diseases and More), End-User Setting (Hospitals & Specialty Clinics and More) and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Telemonitoring Systems Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Telemonitoring Systems Market with other markets in Healthcare Industry

Telemonitoring Systems Market Analysis by Mordor Intelligence

The telemonitoring systems market stands at USD 5.14 billion in 2025 and is forecast to reach USD 9.57 billion by 2030, reflecting a robust 13.24% CAGR. This growth reflects the rapid transition from episodic care to home-based, predictive models that use artificial intelligence (AI) to convert continuous data feeds into real-time clinical guidance.[1]Jonathan Blum, “Lessons from CMS’ Acute Hospital Care at Home Initiative,” Centers for Medicare & Medicaid Services, cms.gov Recent reimbursement changes—most notably the Centers for Medicare & Medicaid Services (CMS) expansion of Remote Patient Monitoring (RPM) and the debut of Advanced Primary Care Management billing codes—have made these systems financially sustainable for providers. AI-equipped cardiac platforms now detect atrial fibrillation weeks earlier than legacy monitors, while consumer-grade continuous glucose monitors (CGMs) are moving beyond diabetes care to wider metabolic-health applications. North America leads adoption thanks to aggressive Hospital-at-Home rollouts, whereas Asia-Pacific emerges as the fastest-growing region on the back of 5G infrastructure and supportive digital-health policies. 

Key Report Takeaways

  • By product type, cardiac systems led with 31.43% revenue share in 2024; glucose-level systems are projected to expand at a 17.55% CAGR through 2030.
  • By component, devices accounted for 82.12% of the telemonitoring systems market share in 2024, while software platforms are forecast to grow at a 15.34% CAGR between 2025-2030.
  • By connectivity technology, Bluetooth/Low-Energy held 35.45% share in 2024; cellular networks are expected to post the fastest 16.78% CAGR through 2030.
  • By application, cardiovascular monitoring captured 24.56% of the telemonitoring systems market size in 2024, whereas diabetes management is advancing at a 16.32% CAGR to 2030.
  • By end-user setting, hospitals and specialty clinics maintained 43.21% share in 2024, while home-care environments are set to rise at a 15.88% CAGR over the forecast period.
  • By geography, North America dominated with 39.87% market share in 2024; Asia-Pacific is the fastest-growing region, climbing at a 14.76% CAGR through 2030.

Segment Analysis

By Product Type: Cardiac Systems Drive Clinical Validation

Cardiac platforms held 31.43% of telemonitoring systems market share in 2024, thanks to well-established reimbursement and FDA-cleared devices such as Abbott’s Assert-IQ, which offers six-year battery life and AI-enhanced arrhythmia detection. Glucose-monitoring devices are projected to expand at 17.55% CAGR, propelled by consumer wellness trends and OTC CGM approvals. This segment’s rise widens the telemonitoring systems market by attracting non-diabetic users keen on metabolic fitness. 

Preventive care models are spurring multi-parameter monitors that aggregate ECG, SpO₂, and blood pressure in one wearable, echoing the market’s pivot from single-metric tools to holistic platforms. COPD and hypertension devices fill niche needs but face slower growth until broader clinical guidelines endorse remote management.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Component: Software Platforms Accelerate Integration

Hardware captured 82.12% revenue in 2024, but software is advancing at a 15.34% CAGR, reflecting the industry’s recognition that data unification and algorithmic insights drive value. Philips’ viQtor integration exemplifies software-centric ecosystems that streamline clinician dashboards. Telemonitoring systems market size for cloud-first analytics modules is expected to grow steadily as AI models mature and payors reimburse decision-support outputs. 

Services—from implementation to training—form the glue that binds devices and platforms, ensuring long-term user adoption. GE HealthCare’s CareIntellect uses generative AI to condense cancer patient records, cutting data-retrieval time and underscoring how software reduces cognitive load.

By Connectivity Technology: Cellular Networks Enable Mobility

Bluetooth and BLE retained 35.45% share in 2024 due to energy economy and universal smartphone pairing. Cellular links, however, will notch the fastest 16.78% CAGR because they bypass Wi-Fi dependency, addressing gaps highlighted in broadband-constrained regions. The telemonitoring systems market size tied to cellular modules also benefits from favorable data-only subscription pricing by mobile operators. 

The arrival of 5G private networks allows near-instant transfers crucial for imaging and remote interventions, as evidenced by China’s stand-alone deployments. Mesh strategies—combining Wi-Fi, cellular, and LP-WAN—are gaining traction as vendors build redundancy into rural-care solutions.

By Application/Condition: Diabetes Management Accelerates Growth

Cardiovascular monitoring remained dominant, capturing 24.56% of telemonitoring systems market size in 2024, buoyed by evidence that AI-based ECG analytics reduce stroke risk by 45%. Diabetes management is scaling at 16.32% CAGR, driven by automated insulin delivery ecosystems that personalize dosing. 

Respiratory-care telemonitoring gains momentum through AI-enabled spirometry and inhaler-adherence sensors, while hypertension platforms integrate with smartwatch BP cuffs, transforming patient self-management. Rising awareness of chronic-kidney disease, oncology survivorship, and post-operative monitoring will open adjacencies for vendors seeking to diversify revenue.

Telemonitoring Systems Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End-User Setting: Home Care Transforms Healthcare Delivery

Hospitals and specialty clinics retained 43.21% of telemonitoring systems market share in 2024 by embedding RPM into established protocols and electronic records. Yet home-care settings post a 15.88% CAGR, reflecting patient preference for comfort and the CMS Acute Hospital Care at Home waiver’s cost-saving results. Telemonitoring systems industry alliances with home-health agencies are accelerating as value-based contracts reward readmission avoidance. 

Long-term-care facilities adopt fall-detection wearables and smart beds to extend staff capacity, whereas ambulatory surgical centers use short-term RPM bundles to prevent post-discharge complications. The Toronto Grace program illustrates scalability, overseeing 16,000 clients with ambitions to reach 30,000, proving remote monitoring is viable at province-wide scale.

Geography Analysis

North America commanded 39.87% of telemonitoring systems market share in 2024 on the back of reimbursement leadership and mature provider networks. CMS data show 31,000 patients treated via Hospital-at-Home since 2020 with lower mortality and spending, reinforcing payor confidence in remote care. Mass General Brigham’s 70-bed capacity demonstrates how large systems leverage telemonitoring to free inpatient beds for higher acuity cases. Enterprise deals between Philips and leading health systems are translating into nationwide rollouts of AI-enabled dashboards.

Asia-Pacific is the fastest-growing territory with a 14.76% CAGR to 2030, supported by proactive digital-health policies. Japan’s 7.29% market expansion underscores how demographic pressure catalyzes technology uptake, whereas China’s 5G private networks create infrastructure readiness for always-on monitoring. Bibliometric analysis reveals China jumped from 10th to 6th in telemedicine publications post-pandemic, reflecting amplified innovation spending.

Europe posts steady growth anchored by the WHO Regional Digital Health Action Plan, with Norway’s AI-assisted teleradiology programs setting benchmarks for cross-border data-sharing. Yet reimbursement fragmentation slows deployment speed. The forthcoming European Health Data Space and HTA regulation aim to harmonize evaluation criteria, which could reduce launch timelines.

Elsewhere, Middle East, Africa, and South America remain nascent but promising. Pilot programs in the United Arab Emirates and Brazil demonstrate viability once regulatory guardrails and broadband build-outs advance.

Telemonitoring Systems Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The telemonitoring systems market shows moderate concentration. Philips pairs deep imaging heritage with acquisitions such as smartQare to offer end-to-end ecosystems. Abbott’s portfolio spans cardiac monitors and CGMs, enabling cross-selling and data pooling that strengthen algorithm performance. Boston Scientific differentiates with HeartLogic and Bluetooth-enabled implantables that feed cloud analytics.

Platform players such as Teladoc Health pursue inorganic growth, acquiring Catapult Health and UpLift to widen chronic-condition programs. GE HealthCare invests in AI labs and oncology-centric RPM, signaling a shift from modality sales to subscription analytics. Niche start-ups focus on workflow software and rural connectivity, aiming to license technology to the giants.

Competitive success now hinges on regulatory savvy, payer engagement, and data-science excellence more than on hardware innovation alone. Vendors with clinically validated algorithms, broad device portfolios, and integration APIs will retain pricing power.

Telemonitoring Systems Industry Leaders

  1. Abbott Laboratories

  2. Koninklijke Philips NV

  3. GE Healthcare

  4. Medtronics plc

  5. Boston Scientific Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Abbott Laboratories, Care Innovations LLC
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2025: Philips and Mass General Brigham launched a collaboration to integrate live AI insights into continuous heart monitoring.
  • February 2025: Teladoc Health acquired Catapult Health for USD 65 million to expand at-home testing and chronic-care enrollment.
  • January 2025: Teladoc Health partnered with Amazon Health to extend cardiometabolic programs to more than 1 million members.

Table of Contents for Telemonitoring Systems Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Chronic Disease Burden & Ageing Population
    • 4.2.2 Expansion Of Reimbursement Codes For RPM & Telehealth
    • 4.2.3 Tech Advances In Wearables & 5G Connectivity
    • 4.2.4 Pressure To Cut Readmissions & Hospital Costs
    • 4.2.5 Capacity-Driven “Hospital-At-Home” Roll-Outs
    • 4.2.6 AI-Powered Predictive Analytics Turns RPM Data Into Billable Insight
  • 4.3 Market Restraints
    • 4.3.1 Rural ICT & Broadband Gaps
    • 4.3.2 Cyber-Security / Privacy Breaches
    • 4.3.3 Clinician Workflow Overload From Raw RPM Data
    • 4.3.4 Patchy Non-US Reimbursement & Evidence Thresholds
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technology Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size and Growth Forecasts (Value-USD)

  • 5.1 By Product Type
    • 5.1.1 COPD Telemonitoring Systems
    • 5.1.2 Glucose Level Telemonitoring Systems
    • 5.1.3 Cardiac Telemonitoring Systems
    • 5.1.4 Blood-Pressure Telemonitoring Systems
    • 5.1.5 Multi-parameter/Other Systems
  • 5.2 By Component
    • 5.2.1 Devices
    • 5.2.2 Software Platforms
    • 5.2.3 Services
  • 5.3 By Connectivity Technology
    • 5.3.1 Bluetooth / Low-Energy
    • 5.3.2 Cellular / NB-IoT
    • 5.3.3 Wi-Fi / WLAN
    • 5.3.4 Wired
  • 5.4 By Application / Condition
    • 5.4.1 Cardiovascular Diseases
    • 5.4.2 Diabetes
    • 5.4.3 Respiratory Diseases (e.g., COPD, Asthma)
    • 5.4.4 Other Chronic & Acute Conditions
  • 5.5 By End-User Setting
    • 5.5.1 Hospitals & Specialty Clinics
    • 5.5.2 Home-care Settings
    • 5.5.3 Long-term Care Facilities
    • 5.5.4 Ambulatory Surgical & Out-patient Centers
  • 5.6 By Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 Koninklijke Philips N.V.
    • 6.3.2 Medtronic plc
    • 6.3.3 GE HealthCare Technologies Inc.
    • 6.3.4 Abbott Laboratories
    • 6.3.5 Resideo (Honeywell HomMed)
    • 6.3.6 Boston Scientific Corp.
    • 6.3.7 Omron Corporation
    • 6.3.8 Nihon Kohden Corporation
    • 6.3.9 Dexcom Inc.
    • 6.3.10 Teladoc Health Inc.
    • 6.3.11 Masimo Corporation
    • 6.3.12 Aerotel Medical Systems Ltd.
    • 6.3.13 InfoBionic Inc.
    • 6.3.14 iRhythm Technologies Inc.
    • 6.3.15 AliveCor Inc.
    • 6.3.16 VitalConnect Inc.
    • 6.3.17 Care Innovation LLC (Intel-GE JV)
    • 6.3.18 AMD Global Telemedicine Inc.
    • 6.3.19 SHL Telemedicine Ltd.
    • 6.3.20 ResMed Inc.
    • 6.3.21 Qardio Inc.
    • 6.3.22 Withings
    • 6.3.23 VivaLNK

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Telemonitoring Systems Market Report Scope

Telemonitoring has various modes of operations, such as real-time mode, wherein the data of a patient is available on the server, and store-and-forward mode involves accessing the data at a later time. The market product comprises of COPD Telemonitoring System, Glucose Level Telemonitoring System, Cardiac Telemonitoring System, and others.

By Product Type COPD Telemonitoring Systems
Glucose Level Telemonitoring Systems
Cardiac Telemonitoring Systems
Blood-Pressure Telemonitoring Systems
Multi-parameter/Other Systems
By Component Devices
Software Platforms
Services
By Connectivity Technology Bluetooth / Low-Energy
Cellular / NB-IoT
Wi-Fi / WLAN
Wired
By Application / Condition Cardiovascular Diseases
Diabetes
Respiratory Diseases (e.g., COPD, Asthma)
Other Chronic & Acute Conditions
By End-User Setting Hospitals & Specialty Clinics
Home-care Settings
Long-term Care Facilities
Ambulatory Surgical & Out-patient Centers
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product Type
COPD Telemonitoring Systems
Glucose Level Telemonitoring Systems
Cardiac Telemonitoring Systems
Blood-Pressure Telemonitoring Systems
Multi-parameter/Other Systems
By Component
Devices
Software Platforms
Services
By Connectivity Technology
Bluetooth / Low-Energy
Cellular / NB-IoT
Wi-Fi / WLAN
Wired
By Application / Condition
Cardiovascular Diseases
Diabetes
Respiratory Diseases (e.g., COPD, Asthma)
Other Chronic & Acute Conditions
By End-User Setting
Hospitals & Specialty Clinics
Home-care Settings
Long-term Care Facilities
Ambulatory Surgical & Out-patient Centers
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

1. What is the projected value of the telemonitoring systems market by 2030?

The market is forecast to reach USD 9.57 billion by 2030, growing at a 13.24% CAGR.

2. Which product segment currently leads the telemonitoring systems market?

Cardiac telemonitoring systems lead with 31.43% revenue share in 2024.

3. Why are software platforms the fastest-growing component?

Providers need integrated analytics and AI decision support, driving software to a 15.34% CAGR.

4. How does reimbursement influence market growth?

CMS’s expanded RPM and Advanced Primary Care Management codes create multiple payment paths, accelerating US adoption.

5. What geographic region is expanding the quickest?

Asia-Pacific is projected to grow at 14.76% CAGR, boosted by 5G rollouts and supportive digital-health policies.

Telemonitoring Systems Market Report Snapshots